1 Observed number of pregnancies (all women) |
14 |
8752 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.72 [0.52, 0.99] |
2 Observed number of pregnancies (by risk status) |
1 |
4071 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.92 [0.55, 1.55] |
2.1 High‐risk women |
1 |
1235 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.32 [0.67, 2.60] |
2.2 Low‐risk women |
1 |
2836 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.59 [0.25, 1.35] |
3 Observed number of pregnancies (time from intercourse) |
2 |
6074 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.85 [0.56, 1.28] |
3.1 Within 72 h |
2 |
5553 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.82 [0.53, 1.27] |
3.2 Later than 72 h |
2 |
521 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.11 [0.35, 3.57] |
4 Any side effect |
3 |
609 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.26 [0.17, 0.38] |
5 Specific side effect |
8 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
5.1 Nausea |
5 |
6384 |
Risk Ratio (M‐H, Random, 95% CI) |
0.95 [0.84, 1.09] |
5.2 Vomiting |
3 |
6085 |
Risk Ratio (M‐H, Random, 95% CI) |
1.22 [0.55, 2.68] |
5.3 Headache |
3 |
6082 |
Risk Ratio (M‐H, Random, 95% CI) |
1.06 [0.83, 1.37] |
5.4 Dizziness |
4 |
6181 |
Risk Ratio (M‐H, Random, 95% CI) |
0.92 [0.79, 1.08] |
5.5 Fatigue |
3 |
6077 |
Risk Ratio (M‐H, Random, 95% CI) |
1.06 [0.94, 1.21] |
5.6 Breast tenderness |
3 |
6084 |
Risk Ratio (M‐H, Random, 95% CI) |
1.03 [0.88, 1.21] |
5.7 Diarrhoea |
2 |
4184 |
Risk Ratio (M‐H, Random, 95% CI) |
1.26 [0.93, 1.73] |
5.8 Spotting/bleeding after treatment |
5 |
4598 |
Risk Ratio (M‐H, Random, 95% CI) |
0.61 [0.54, 0.69] |
5.9 Low abdominal pain |
4 |
5105 |
Risk Ratio (M‐H, Random, 95% CI) |
0.94 [0.83, 1.06] |
5.10 Hot flushes |
1 |
723 |
Risk Ratio (M‐H, Random, 95% CI) |
0.93 [0.65, 1.33] |
6 Menses |
9 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
6.1 Early |
5 |
1800 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.45 [0.35, 0.59] |
6.2 Delay |
9 |
7520 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.70 [1.48, 1.97] |
7 ITT (all loss follow‐up as pregnancy in LNG, and no preg in Mifepristone) |
9 |
8429 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.70 [0.50, 0.98] |
8 ITT (all loss follow‐up as no pregnancy in LNG, and preg in Mifepristone) |
9 |
8429 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.90 [0.76, 1.05] |